Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D

Published by	Fuji-Keizai U.S.A., Inc.
Published	January, 2010	Product code	107544
Content info	141 PAGES
Price	US $ 1495 Hard Copy: English Version US $ 1495 Hard Copy: Japanese Version US $ 2295 PDF by E-mail (Department License): English Version US $ 2295 PDF by E-mail (Department License): Japanese Version US $ 3495 PDF by E-mail (Corporate License): English Version US $ 3495 PDF by E-mail (Corporate License): Japanese Version

Introduction
Related Reports

Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D published by Fuji-Keizai U.S.A., Inc. in January, 2010. This report consists of 141 PAGES and the price starts from US $ 1495.

Introduction

Abstract

This report reviews, analyzes and sizes the stem cell R&D tools & tech product and stem cell therapeutic markets. The study uncovers interesting information about key equipment, consumables, reagents, software and services that are marketed to life science researchers working in stem cell R&D.

The report reviews the sources of government and private stem cell research investment. Stem cell R&D work is underway at universities, government labs, institutes, cancer centers, hospitals and at drug makers or cell therapeutics companies.

Major drug makers have taken keen interest in the potential opportunity to improve their chances for making safer future drugs by using pluripotent stem cells to make customized disease focused cells used in cell screening campaigns used in pre-clinical drug development. The customized stem cell-derived human cells would eliminate the need to sacrifice millions of lab animals that are currently used for drug safety testing.

The study examines the stem cell therapeutic market which is poised for growth within the next five years. The report reviews the current stem cell transplantation business and suggests when new stem cell based therapeutics might become available

The financial assessment section sizes the market and discusses the five year revenue projection. The market is segmented by major product areas and by major R&D disease focus. This market is also segmented by major world regions to see the growth or how the market share might change.

This study reviews and analyzes major company alliances, M&As, and patents that were issued during the last two years. Data tables summarize the alliances, M&As and patents.

This research report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc. More than 41 detailed tables or figures provide key data about items such as strategic alliances, M&As, market size, segments and the like. This report includes twenty-five company profiles that provide the reader a snapshot of the companies' focus or activities. The provided Internet links help readers access companies' own web sites for further review.

Targeted the Stem Cell R&D and Therapeutic Product Market:

Consumables
- Commercial stem cell kits, Assays, Labware, etc.
- Bulk reagents, Growth media, Chemicals, Probes, Antibodies, etc.
- Stem cell lines
- Biochips, Microplates and related

Equipment
- Flow cytometry, FACS, Cell Sorters, etc.
- HCS/A imaging cytometry
- HT(FLIPR) fluorometric imaging plate readers
- Automated ion channel equipment
- LCM & miRNA screening equipment
- DNA biochip/PCR equipment

Software
- System control software
- Application software for cell analysis

Services
- Drug development & assay support
- Drug safety assay development & screening

Other Tools & Technologies
- Misc. Biotechnologies, IT, DBMS, etc.

Stem Cell Therapies
- Existing stem cell transplant therapy
- Adult stem cell based therapy
- Embryonic stem cell based therapy

Targeted Company:

Applied Precision, Inc., Axxam SpA, BD (Becton, Dickinson & Co.), Beckman Coulter, Inc., GE Healthcare Life Sciences, Geron Corporation, Luminex Corporation, Millipore Corporation, PerkinElmer Life and Analytical Sciences, Tecan Group Ltd., ThermoFisher Scientific Inc., Consumables - Reagents, Assays, Media, Cell Lines, DiscoveRx Corporation, Life Techologies, Inc., MaxCyte, Inc., Odyssey Thera, Inc., Panomics (Affymetrix), Sigma-Aldrich, Software Solutions, Definiens AG, Stem Cell Screening/Analysis, America Stem Cell Inc., AuxoCell Laboratories, Inc., California Stem Cell, Inc., Capricor Inc., Cenix Bioscience GmbH, GIRUS Life Sciences, Inc., Fluidigm Corporation.

Report Statistics

Published: January 15, 2010
Total Page: 141 pages

Executive Summary

1. Overview of Cell Screening and Stem Cell Tools & Technologies Market for R&D

1.1 Overview of Cell Screening and Stem Cell Tools & Techs for R&D & Therapeutics
- 1.1.1 Stem Cell Field Has Grown Rapidly
  - Figure 1. The Stem Cell R&D and Therapeutic Product Market Ecosystem
- 1.1.2 Definition and Brief History of Cell Screening and Stem Cell Tools & Techs for R&D & Therapeutics
  - Table 1. Highlights of Stem Cell Research Milestones
- 1.1.3 Cell Screening and Stem Cell R&D Tool & Tech Mechanisms
- 1.1.4 Diseases, Conditions & Demographics Targeted by R&D Using Cell Screening Tools in Stem Cell R&D
  - Table 2. Major Diseases by Mortality, Incidence and Prevalence
- 1.1.5 Tools, Technologies, Equipment & Products for Stem Cell R&D
- 1.1.6 Cell Screening Assays for Drug R&D
- 1.1.7 Stem Cell-based Therapeutics for Major Diseases
1.2 Cell Screening, Stem Cell R&D Applications
- 1.2.1 Basic Academic Research Applications
  - Figure 2. Survey of PubMed Articles Involving Stem Cells
- 1.2.2 Applied Research Applications
- 1.2.3 Pharma/ Biotech Drug R&D Applications

2. Major Alliances, M&As and IP

2.1 Summary of Key Alliances and M&As
- 2.1.1 Comparing Alliances and M&A' s by Half-Years
  - Table 3. Alliances By Half-Years - Summary, ‘07H2-‘09H1
  - Table 4. Alliances By Quarters - Detail, ‘07Q3-‘09Q2
2.2 Details of Key Alliances and M&As
- Table 5. Alliances, Jan-1-2009 to Jun-30-2009
- Table 6. Alliances, Jul-1-2008 to Dec-31-2008
- Table 7. Alliances, Jul-1-2007 to Dec-31-2007
2.3 Patents, Business Development and Challenges
- 2.3.1 Leading Organizations Holding Patents Involving Cell Screening and Stem Cell R&D Technologies.
  - Table 8. Top 20 Companies by Patents in Cell Screening and Stem Cell R&D
  - Table 9. Top 20 Academic Organizations by Patents in Cell Screening and Stem Cell R&D
- 2.3.2 Business Development and Challenges
- 2.3.3 IP Challenges

3. The Market and Outlook for the Cell Screening, Stem Cell Products Industry

3.1 The Total Cell Screening, Stem Cell Product Market Size, 2008~2013
- 3.1.1 Summary of Total Product Market Size and Growth Rate
  - Figure 3. WW Total Stem Cell Product Market Size
  - Table 10. WW Total Stem Cell Product Market Size
- 3.1.2 WW Total Market by Stem Cell Products By Segments
  - Figure 4. WW Total Stem Cell Product Market By Top Segments
  - Table 11. WW Total Stem Cell Product Market By Top Segments
3.2 WW Stem Cell R&D Tools & Technologies Market
- 3.2.1 Tools & Technologies Segments
  - Figure 5. WW Stem Cell R&D Tools & Techs. By Key Product Segments $M
  - Table 12. WW Stem Cell R&D Tools & Techs. By Key Product Segments $M
- 3.2.2 Methodology: Stem Cell R&D Tools & Tech. Market By Key Product Segments
- 3.2.3 Consumables
- 3.2.4 Equipment
- 3.2.5 Software
- 3.2.6 Services
- 3.2.7 Others
- 3.2.8 Stem Cell R&D Tools & Technology Key Product Segment Market Shares, 2008 & 2013
  - Figure 6. Stem Cell R&D Tools & Technology Key Product Segment Market Shares, 2008 & 2013
- 3.2.9 WW Stem Cell R&D Tools & Techs. By Product Sub-Segments $M
  - Table 13. WW Stem Cell R&D Tools & Techs. By Product Sub-Segments $M
3.3 WW Stem Cell R&D Tools & Technologies Market by Applications
- 3.3.1 Basic Research
  - Figure 7. WW Stem Cell R&D Tools & Technologies Market By Application $M
  - Table 14. WW Stem Cell R&D Tools & Technologies Market By Application $M
- 3.3.2 Applied R&D
- 3.3.3 Drug Discovery R&D
3.4 WW Stem Cell R&D Tools & Technologies Market by Disease Focus
- 3.4.1 Major Disease Segments
  - Figure 8. WW Stem Cell R&D Tools & Tech Market By Disease Focus $M
  - Table 15. WW Stem Cell R&D Tools & Tech Market By Disease Focus $M
- 3.4.2 Cancers
- 3.4.3 Cardiovascular
- 3.4.5 Hematopoietic & Transplantation
- 3.4.6 Respiratory
- 3.4.7 Liver
- 3.4.8 Musculoskeletal
- 3.4.9 Diabetes
- 3.4.10 Other Diseases
3.5 WW Stem Cell R&D Tools & Technologies Market by WW Regions
- 3.5.1 Key WW Region Segments
  - Figure 9. WW Stem Cell R&D Tools & Technologies Market By Region $M
  - Table 16. WW Stem Cell R&D Tools & Technologies Market By Region $M
- 3.5.2 North America
- 3.5.3 Europe
- 3.5.4 Japan/ Asia Pacific
- 3.5.5 ROW
- 3.5.6 Stem Cell R&D Tools & Technologies Region Market Shares, 2009 & 2013
  - Figure 10. Stem Cell R&D Tools & Technologies Region Market Shares, 2009 & 2013
3.6 WW Stem Cell Therapeutic Product Market
- 3.6.1 Key Therapeutics Market Segments
  - Figure 11. WW Stem Cell Therapeutic Market By Key Product Segments
  - Table 17. WW Stem Cell Therapeutic Market By Key Product Segments
- 3.6.2 Methodologies: Stem Cell Therapeutic Market
- 3.6.3 Existing Stem Transplantation
- 3.6.4 Near Term Adult Stem Cell-based Therapy Products
- 3.6.5 Future Embryonic Stem Cell-based Therapy Products
3.7 Stem Cell R&D Tools & Techs Vendor Market Share Rank (2009)
- Table 18. Leading ‘Equipment' Vendors by Market Share Rank
- Table 19. Leading ‘Consumables' Vendors by Market Share Rank

4. Activities of Selected Companies

4.1 Equipment Platforms
- 4.1.1 ~ 4.1.11 (Total 11 Companies)
4.2 Consumables - Reagents, Assays, Media, Cell Lines
- 4.2.1 ~ 4.2.6 (Total 6 Companies)
4.3 Software Solutions
- 4.3.1 (1 company)
4.4 Stem Cell Screening/Analysis
- 4.4.1 ~ 4.4.7 (Total 7 Companies)

5. Conclusions and New Business Opportunities

5.1 The Future of Cell Screening and Stem Cell R&D Products
- 5.1.1 Stem Cell R&D Tools & Technologies
  - 5.1.1.1 Consumables, Stem Cells & Technologies for Stem Cell R&D
    - Table 20. Selected Consumables, Reagents, Stem Cells
  - 5.1.1.2 Equipment for Stem Cell Screening
    - Table 21. Selected Equipment for Stem Cell Screening Software
    - Table 22. Selected Software for Stem Cell Screening
  - 5.1.1.3 Software
  - 5.1.1.4 Services
    - Table 23. Selected Services for Stem Cell R&D
- 5.1.2 Stem Cell-Based Therapeutics
  - Table 24. Stem Cell Therapeutic Clinical Pipeline (Phase II/III to Phase IV)
5.2 Likely Cell Screening and Stem Cell R&D Tools & Tech Success and Failure Factors
- 5.2.1 Widespread Public Mind-Share of Stem Cell Controversies Promotes Interest or Awareness of Stem Cell Research
- 5.2.2 The Challenge of Stem Cell Research Issues
- 5.2.3 WW Government & Private Investment in Stem Cell R&D Drive the Product Market
  - Table 25. WW Government & Private Investment Spending for Stem Cell R&D
- 5.2.4 US Presidential Election, Down Economy, Economic Stimulus
- 5.2.5 M&As Drive New Business for Stem Cell R&D Tool & Tech Companies
  - Table 26. Key M&As of Stem Cell R&D Tool & Tech Companies
5.3 Cell Screening and Stem Cell R&D Business Opportunities or Commercial Implications
- 5.3.1 Business Opportunities for American and European Companies
  - 5.3.1.1 Stem Cell R&D Tools and Techs
  - 5.3.1.2 Explore Other WW Regions for Cost Savings or New Customers
  - 5.3.1.3 Enter Asia for Business Opportunities
- 5.3.2 New Business Opportunities for Japanese and Asian Companies

6. Appendix

6.1 Glossary - Life Science Terms
6.2 Key Life Science R&D Centers
- Table 27. Large International Life Science R&D Centers
6.3 R&D Tool & Tech Suppliers
- Table 28. Cell Screening R&D Tools & Techs. Suppliers
- Table 29. Stem Cell R&D Suppliers By Product Focus
- Table 30. Stem Cell Therapeutic Companies